Couples or individuals with infertility, advanced reproductive age, male factor infertility, or cancer/elective fertility preservation needs who require individualized assisted reproductive care.
Our center provides comprehensive assisted reproductive services, including infertility evaluation, ovulation induction, in vitro fertilization, intracytoplasmic sperm injection, embryo culture, time-lapse embryo culture, gamete and embryo cryopreservation, and individualized treatment for advanced-age, male factor, and complex infertility cases. With multiple pioneering successful cases in Southern Taiwan, Taiwan, and Asia, the center has maintained CAP accreditation since 2022, establishing standardized laboratory procedures and rigorous quality management. Through multidisciplinary collaboration, precision treatment strategies, and continuous technological innovation, we are committed to providing safe, stable, patient-centered, and holistic infertility care.
July 1989 – Birth of the first IVF baby in Southern Taiwan
March 1992 – First successful pregnancy using frozen embryos in Southern Taiwan
May 1996 – First successful pregnancy in Asia using intracytoplasmic sperm injection without PVP
March 1997 – First successful pregnancy in Asia using frozen testicular sperm combined with microinjection technology
September 2005 – Birth of Taiwan’s first baby from a vitrified frozen blastocyst-stage embryo
CAP accreditation since 2022
In 2023, the total number of treatment cycles was 808, including oocyte retrieval cycles and frozen embryo transfer cycles.
Blastocyst cryosurvival rate 98.3%
ICSI damage rate 3%
The patient satisfaction survey comprised ten indicators. The overall mean score was 4.55 out of 5 in 2024, compared with 4.56 in 2020, 4.52 in 2021, 4.70 in 2022, and 4.75 in 2023. These consistently high scores indicate that patients undergoing IVF treatment reported a high level of overall satisfaction with the services provided by the department.
CAP accreditation since 2022
